Analysis of lectin binding sites in the gut of hooded Lister rats with special emphasis on recently detected lectins

Lectins: from basic science to clinical application in cancer prevention

Many physiological functions are attributable to lectin-carbohydrate interactions. Lectins are currently being studied for their ability to destroy tumour growth by binding to specific carbohydrate motifs on cancer cells. Cell-surface molecules, including growth factor receptors are often glycosylated, and lectins may act by binding to these. Certain lectins effect the proliferation of intestinal epithelial cells. This effect is cell-type and lectin specific and occurs in the intestine of intact animals, in human colonic explants and colorectal cancer cell lines. Lectins present in mammalian tissue are involved in cell-matrix adhesion, differentiation, lymphocyte circulation and immunomodulation. Mammalian lectins contribute to detection, diagnosis and prognosis of tumour cells, and can be targeted for therapy. New lectins of plant and mammalian origin that have one or more of these functions are currently being developed as tools that could be used to target tumour cells.

Histological, histochemical, and fine structural observations on the lymph node of the common seal (Phoca vitulina) and the grey seal (Halichoerus grypus)

BACKGROUND

The recent seal death epizootic prompted interest in their immune system, for which no current morphological data were available.

METHODS

Lymph nodes from adult harbor seals (Phoca vitulina) and grey seals (Halichoerus grypus) were investigated by light microscopy, electron microscopy, and lectin histochemistry.

RESULTS

No significant differences in the lymph node morphology were found between the two species, and the overall organization of the nodes comprises of capsule, trabeculae, cortex, paracortex, and medulla. Capsule and trabeculae are composed of tightly packed collagen and elastic fibrils and are rich in fibroblasts, myofibroblasts, and smooth muscle cells. Unmyelinated nerve fibers are common. The cortex contains numerous secondary follicles with well-developed germinal centers and paracortical areas with high endothelial venules. Antigen-presenting cells and phagocytic macrophages were abundantly present. The medullary cords contain numerous plasma cells. Fibroblastic reticulum cells are common throughout the parenchyma and transverse the sinus. Marginal, radial, and medullary sinuses are lined by littoral cells. The visceral lining of the sinuses is marked by macrophages and by numerous mast cells.

CONCLUSIONS

The morphology of seal lymph nodes does not differ significantly from that of terrestrial mammals. Earlier functional conclusions concerning seal lymph nodes are substantiated by this morphological study.

Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches

The nature of cell-associated carbohydrates in the human intestine that may mediate transepithelial transport of bacterial and dietary lectins and their processing by the lymphoid cells of Peyer's patches is not known. Because the cell surface carbohydrate receptors for lectins may vary in different species, the glycoconjugates of human and mouse follicle-associated epithelium and gut-associated lymphoid tissue were compared. A panel of 27, mainly recently isolated, lectins were used to identify glycoconjugate expression in M-cells, enterocytes, goblet cells, lymphocytes and macrophages in mouse and human intestine. Mouse M-cells were exclusively labelled by fucose-specific lectins but in human follicle-associated epithelium no distinct M-cell staining pattern was observed. In the human Peyer's patches, Bryonia dioica lectin bound selectively to paracortical T-lymphocytes and Chelidonium majus lectin to germinal centre B-cells. Certain mannose-specific lectins (Galanthus nivalis, Hippeastrum hybrid) stained the tingible body macrophages in the germinal centre of human Peyer's patches but labelled the macrophages in the paracortical T-cell region of the mouse. The results indicate distinct differences in glycosylation between mouse and human Peyer's patches and their associated lymphoid cells. When considering cell surface glycoconjugates as target molecules for the gut immune system, care has to be taken to choose the appropriate lectin for each species.

Biochemical, histochemical and cell biological investigations on the actions of mistletoe lectins I, II and III with human breast cancer cell lines

Cytotoxicity of the mistletoe lectins I, II and III towards six human breast cancer cell lines was assessed using the Mossman assay. In addition, binding of the three mistletoe lectins to the separated membrane glycoproteins of these cell lines, the binding and uptake of these lectins into the cells in tissue culture and the binding of the lectins to histological preparations of these cell lines were analysed. The results indicate that there are quantitative differences concerning the toxicity of these three lectins towards the different cell lines. Furthermore, the lectin binding pattern in the cell lines differed. In Western blots, several membrane glycoproteins were labelled by the lectins. Our results indicate subtle differences between the three lectins with regard to the parameters mentioned above; however, the toxicity of all three lectins from mistletoe is so similar that they all seem suitable for the construction of immunotoxins.

Binding patterns of mistletoe lectins I, II and III to microglia and Alzheimer plaque glycoproteins in human brains

Glycoconjugates of microglial cells and in some cases those glycoconjugates present in the amyloid plaques in Alzheimer's disease in the cerebral cortex can be stained with a lectin from mistletoe (ML-I) using a labour-intensive and time-consuming indirect immunoperoxidase technique. In order to simplify the staining method and to test the staining characteristics of the other recently isolated mistletoe lectins (ML-II, ML-III) biotinylated MLs I-III were used together with an avidin-alkaline phosphatase-complex for visualisation. Our findings indicate that this new improved technique can also be used for detection of microglial cells and is considerably faster than the old method. In addition to microglial cells, ML-I labelled plaque glycoproteins possibly indicating that glycoconjugates derived from microglia can be detected in plaques. In contrast to ML-I, both ML-II and ML-III did not stain microglial cells.